Feinstein Institutes’ Research Journal Molecular Medicine Increases Impact Factor
The impact factor of the international peer-reviewed medical research journal Molecular Medicine , which is published by The Feinstein Institutes for Medical Research and Springer Natures BioMed Central, rose to 6.354 the highest score since the publication was founded in 1994.
- The impact factor of the international peer-reviewed medical research journal Molecular Medicine , which is published by The Feinstein Institutes for Medical Research and Springer Natures BioMed Central, rose to 6.354 the highest score since the publication was founded in 1994.
- Impact factors help inform fellow researchers about the reach and influence a medical journal has on the larger scientific community and why they should consider submitting their studies for publication, said Betty Diamond, MD, director of the Institute of Molecular Medicine at the Feinstein Institutes and Editor-in-Chief of Molecular Medicine.
- In addition to Molecular Medicine, the Feinstein Institutes publishes the journal Bioelectronic Medicine in partnership with BioMed Central , part of Springer Nature .
- Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.